Description
The UCSF Clinical Pharmacology and Therapeutics (CPT) Postdoctoral Training Program is a research-intensive, two-year training experience that prepares clinician-scientists to become leaders in clinical pharmacology research within academia, industry, and government. The program seeks candidates whose experience, teaching, research, or community service has prepared them to contribute to our commitment to diversity and excellence.
Clinical pharmacology, in the broadest sense, encompasses:
- Drug discovery
- Clinical development
- Regulatory issues
- Therapeutic use and individualization of drug therapy
- Optimization of drug dosage regimens
- An understanding of drug-induced toxicity
- Measures to prevent or minimize adverse effects of drugs.
Fellows will:
- Participate in mentored research
- Learn via interdisciplinary didactics in clinical pharmacology
- Gain exposure to scientific and ethical issues in research and development
- Present and publish results of scholarly work.
The program meets the fellowship training expectations set forth by the American Board of Clinical Pharmacologyexternal site (opens in a new window) (ABCP) and is a registered member of ABCP. We anticipate that 80 percent of our graduates will obtain board certification in clinical pharmacology.
Fellowship funding comes from National Institute of General Medical Sciences and National Institute of Child Health and Development T32 training grants as well as the UCSF School of Pharmacy Department of Clinical Pharmacy and Dean’s Office.
Eligibility:
- MD or PharmD from an accredited university or equivalent
- MDs must be board-certified
- PharmDs must be eligible for licensure in California by July 1, 2027 and obtain licensure by October 31, 2027
- Priority will be given to candidates with residency training in their early postdoctoral years
- Excellent oral and written communication skills, ethics, professionalism
- Appointees must be citizens or permanent residents of the United States.
